Key Highlights
•
A new study found that combining the arthritis drug ixekizumab with the weight-loss drug tirzepatide led to better disease control in people with psoriatic arthritis who are overweight or obese, compared to using ixekizumab alone. This suggests a promising new treatment strategy that tackles both inflammation and metabolism for complex conditions.
Source →
•
Researchers discovered that a specific genetic deletion in the ABCA7 gene, which is a strong risk factor for Alzheimer’s disease in individuals of African ancestry, disrupts how brain cells handle fats and damages their energy-producing mitochondria. This finding provides a crucial biological explanation for why this genetic variant increases Alzheimer’s risk, pointing toward potential new therapeutic targets.
Source →
•
A new method using droplet digital PCR significantly improves the detection of Coccidioides fungi, which cause Valley Fever, from environmental samples like soil. This advancement is critical for public health, as it allows for better mapping of high-risk areas and earlier warnings to prevent infections in vulnerable populations.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
